Health TidingsMerck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Merck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Read Post »
Health TidingsFDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... FDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... Read Post »
Health TidingsIs Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Is Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Read Post »
Health TidingsSummit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Summit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Read Post »
Health TidingsExpedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Expedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Read Post »
GenericsZydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Zydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Read Post »
Health TidingsFDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... FDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... Read Post »
Health TidingsFDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... FDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... Read Post »
Health TidingsNurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Nurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Read Post »
Manufacturing Mergers & AcquisitionsFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Fujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Read Post »
Health TidingsRoutine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Routine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Read Post »
Health TidingsTavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Tavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Read Post »
Health Tidings Mergers & AcquisitionsEvexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Evexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Read Post »
Health TidingsAcurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Acurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Read Post »
Health TidingsFDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... FDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... Read Post »
GenericsFDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... FDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... Read Post »
Health TidingsGefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Gefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Read Post »
Health TidingsLilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Lilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Read Post »
Health TidingsZai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Zai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Read Post »
Health TidingsEvommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Evommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Read Post »
Health TidingsOtsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Otsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Read Post »
Health TidingsNovel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Novel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Read Post »
Health TidingsTiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Tiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Read Post »
Health TidingsAbivax Advances Obefazimod Toward FDA NDA for Ulcerative Colitis Abivax Advances Obefazimod Toward FDA NDA for Ulcerative Colitis Read Post »
Health Tidings Mergers & AcquisitionsAbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers AbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers Read Post »
Health Tidings Mergers & AcquisitionsRelation, GSK Partner in $110M AI Drug Discovery Collaboration Relation, GSK Partner in $110M AI Drug Discovery Collaboration Read Post »
Health TidingsFDA Grants Priority Review to J&J’s Subcutaneous Amivantamab for ... FDA Grants Priority Review to J&J’s Subcutaneous Amivantamab for ... Read Post »
Health TidingsFDA Advisory Panel Recommends Against Deramiocel for DMD Cardiomyopathy FDA Advisory Panel Recommends Against Deramiocel for DMD Cardiomyopathy Read Post »
Health TidingsOmalizumab Outperformed Multiallergen Oral Immunotherapy in OUTMATCH Trial ... Omalizumab Outperformed Multiallergen Oral Immunotherapy in OUTMATCH Trial ... Read Post »
Health TidingsEyePoint Completes Enrollment in Phase 3 DURAVYU™ Trials for DME EyePoint Completes Enrollment in Phase 3 DURAVYU™ Trials for DME Read Post »
Health TidingsMHRA and NICE Approve Aficamten for Obstructive Hypertrophic Cardiomyopathy MHRA and NICE Approve Aficamten for Obstructive Hypertrophic Cardiomyopathy Read Post »
Health TidingsFDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Site I... FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Site I... Read Post »
Health TidingsEuropean Commission Approves Opzelura for Adults with Moderate Atopic Derma... European Commission Approves Opzelura for Adults with Moderate Atopic Derma... Read Post »
Health TidingsFDA Grants Fast Track Designation to Insilico Medicine’s AI-Designed ... FDA Grants Fast Track Designation to Insilico Medicine’s AI-Designed ... Read Post »
Health TidingsOral Semaglutide Reduces Heavy Drinking in Phase 2 Trial, Supporting Furthe... Oral Semaglutide Reduces Heavy Drinking in Phase 2 Trial, Supporting Furthe... Read Post »
Health TidingsRepatha Wins CHMP Backing to Expand Cardiovascular Risk Reduction in High-R... Repatha Wins CHMP Backing to Expand Cardiovascular Risk Reduction in High-R... Read Post »
Health TidingsEuropean Commission Approves RINVOQ for Severe Alopecia Areata and Non-Segm... European Commission Approves RINVOQ for Severe Alopecia Areata and Non-Segm... Read Post »
Health TidingsFDA Raises Efficacy Concerns Over Replimune’s RP1 Before Advisory Com... FDA Raises Efficacy Concerns Over Replimune’s RP1 Before Advisory Com... Read Post »
Health TidingsLUCERNA Trial Evaluates New First-Line Combination for CLDN18.2-Positive Ga... LUCERNA Trial Evaluates New First-Line Combination for CLDN18.2-Positive Ga... Read Post »
Health TidingsFDA Grants Fast Track Designation to HAYA’s HTX-001 for nHCM FDA Grants Fast Track Designation to HAYA’s HTX-001 for nHCM Read Post »
Health TidingsREGENERA Shows Durable Benefits One Year After Lumpectomy REGENERA Shows Durable Benefits One Year After Lumpectomy Read Post »
Health TidingsOrganogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulce... Organogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulce... Read Post »
Health TidingsGSK’s Risvutatug Rezetecan Extends Progression-Free Survival in Phase III... GSK’s Risvutatug Rezetecan Extends Progression-Free Survival in Phase III... Read Post »
Health Tidings Mergers & AcquisitionsBioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... BioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... Read Post »
Health TidingsIDEAYA Starts IDE892 Phase 1/2 Expansion in MTAP-Deleted PDAC and NSCLC IDEAYA Starts IDE892 Phase 1/2 Expansion in MTAP-Deleted PDAC and NSCLC Read Post »
Health TidingsTwo-Drug Dovato Matches Three-Drug Biktarvy in Viral Suppression Trial Two-Drug Dovato Matches Three-Drug Biktarvy in Viral Suppression Trial Read Post »
Health TidingsFDA Clears Path for Gossamer’s Seralutinib NDA Submission in PAH FDA Clears Path for Gossamer’s Seralutinib NDA Submission in PAH Read Post »
Health Tidings Mergers & Acquisitionsargenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... argenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... Read Post »
Health TidingsMapLight Reports Positive Phase 2 Results for ML-007C-MA in Schizophrenia MapLight Reports Positive Phase 2 Results for ML-007C-MA in Schizophrenia Read Post »
Health TidingsInnoCare’s Fadeucravacitinib Meets Phase III Endpoint in Plaque Psori... InnoCare’s Fadeucravacitinib Meets Phase III Endpoint in Plaque Psori... Read Post »
